The pharmaceutical world is observing a significant shift in blood sugar management with the introduction of GLP-1 transdermal devices. These patches offer a potentially more user-friendly alternative to shots of GLP-1 receptor agonists, reducing the requirement of daily needle sticks. The technology administers the medication directly through t… Read More